Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2,3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease

Figure 1

Preliminary efficacy test. (a, b) Bodyweight and Blood glucose changes in mice. (c–f) Intraperitoneal glucose tolerance test (IGTT) evaluation.

(a)

(b)

(c)

(d)

(e)

(f)